Award

(NU/1804) Research Agreement between Newcastle University and Antaros Medical AB

NEWCASTLE UNIVERSITY

This public procurement record has 1 release in its history.

Award

23 Aug 2022 at 10:17

Summary of the contracting process

Newcastle University has awarded a research agreement to Antaros Medical AB for the provision of MRI analysis services to support a natural history study in subjects with liver disease. The procurement method was a limited procedure, with the award made without prior publication of a call for competition. The contract covers research services in the medical industry category and is currently at the award stage. The agreement was signed on August 18, 2022, with a focus on utilising advanced MR imaging methodologies to analyse liver structure and function for clinical research purposes.

This tender presents an opportunity for businesses in the medical research and imaging sectors to engage in a collaborative project with Newcastle University and Antaros Medical. Companies specialising in research laboratory services, MRI analysis technologies, and proprietary imaging tracers development would be well-suited to compete for potential future extensions of the project. The collaboration between the contracting parties includes the deployment of sophisticated MR imaging modalities, proprietary techniques, and data analysis support to advance knowledge in liver disease research.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

(NU/1804) Research Agreement between Newcastle University and Antaros Medical AB

Notice Description

The services required are the analysis of MRI endpoints for a natural history study in subjects with liver disease. Intention to award a research contract under UK Statutory Instrument 2015 No. 102 Part 2 Chapter 2 Section 3 Regulation 32(1)(b)(ii) and (iii) for provision of MRI analysis to support a natural history cohort study in subjects with liver disease. The contracting party will support deployment, acquisition and downstream analysis of MR imaging modalities including but not limited to 2/3D MRE and contrast enhanced MRI, including the use of their own proprietary techniques, to assess liver structure and function and support clinical research.

Lot Information

Lot 1

The services required are the analysis of MRI endpoints for a natural history study in subjects with liver disease. Intention to award a research contract under UK Statutory Instrument 2015 No. 102 Part 2 Chapter 2 Section 3 Regulation 32(1)(b)(ii) and (iii) for provision of MRI analysis to support a natural history cohort study in subjects with liver disease. The contracting party will support deployment, acquisition and downstream analysis of MR imaging modalities including but not limited to 2/3D MRE and contrast enhanced MRI, including the use of their own proprietary techniques, to assess liver structure and function and support clinical research.

Options: Future option to develop proprietary PET-tracers targeting Collagen-1 and PDGFRbeta that may be relevant in a future extension of the scope of this project.

Procurement Information

The intention is to award a research contract under UK Statutory Instrument 2015 No. 102 Part 2 Chapter 2 Section 3 Regulation 32(1)(b)(ii) and (iii). Where (ii) is the justification for technical reasons and (iii) is the protection of exclusive rights, including intellectual property rights. Antaros Medical have established expertise and experience of deploying advanced MR methodologies in studies that seek to investigate not only liver morphology but also downstream consequences of liver fibrosis such as liver function, portal pressure (including pressure effects on the spleen and portal resistive index) and blood flow to the spleen and kidneys. A range of imaging modalities will be employed in this project including but not limited to liver and spleen stiffness using 2/3D MRE and liver function using uptake of MRI contrast agents, where Antaros Medical have developed quantitative modelling of uptake kinetics to assess liver transporter function. Antaros Medical are also developing proprietary PET-tracers targeting Collagen-1 and PDGFRbeta that may be relevant in a future extension of the scope of this project. These tracers are Antaros Medical proprietary investigational products. Antaros medical will support deployment, acquisition and downstream analysis of MR imaging modalities including but not limited to 2/3D MRE and contrast enhanced MRI to assess liver structure and function and support the research project. In addition, Antaros Medical will collaborate as required with the academic investigators to support the downstream analysis of data, sharing know-how of advanced imaging.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0361f9
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/023436-2022
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

73 - Research and development services and related consultancy services


CPV Codes

73110000 - Research services

73111000 - Research laboratory services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
23 Aug 20223 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
17 Aug 20223 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NEWCASTLE UNIVERSITY
Contact Name
Dr Emma Barksby
Contact Email
emma.barksby@ncl.ac.uk
Contact Phone
+44 1912086298

Buyer Location

Locality
NEWCASTLE
Postcode
NE1 7RU
Post Town
Newcastle upon Tyne
Country
England

Major Region (ITL 1)
TLC North East (England)
Basic Region (ITL 2)
TLC4 Northumberland, Durham and Tyne & Wear
Small Region (ITL 3)
TLC43 Tyneside
Delivery Location
TLC22 Tyneside

Local Authority
Newcastle upon Tyne
Electoral Ward
Monument
Westminster Constituency
Newcastle upon Tyne Central and West

Supplier Information

Number of Suppliers
1
Supplier Name

ANTAROS MEDICAL

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-0361f9-2022-08-23T11:17:50+01:00",
    "date": "2022-08-23T11:17:50+01:00",
    "ocid": "ocds-h6vhtk-0361f9",
    "initiationType": "tender",
    "tender": {
        "id": "DN628672",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "(NU/1804) Research Agreement between Newcastle University and Antaros Medical AB",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "73110000",
            "description": "Research services"
        },
        "mainProcurementCategory": "services",
        "description": "The services required are the analysis of MRI endpoints for a natural history study in subjects with liver disease. Intention to award a research contract under UK Statutory Instrument 2015 No. 102 Part 2 Chapter 2 Section 3 Regulation 32(1)(b)(ii) and (iii) for provision of MRI analysis to support a natural history cohort study in subjects with liver disease. The contracting party will support deployment, acquisition and downstream analysis of MR imaging modalities including but not limited to 2/3D MRE and contrast enhanced MRI, including the use of their own proprietary techniques, to assess liver structure and function and support clinical research.",
        "lots": [
            {
                "id": "1",
                "description": "The services required are the analysis of MRI endpoints for a natural history study in subjects with liver disease. Intention to award a research contract under UK Statutory Instrument 2015 No. 102 Part 2 Chapter 2 Section 3 Regulation 32(1)(b)(ii) and (iii) for provision of MRI analysis to support a natural history cohort study in subjects with liver disease. The contracting party will support deployment, acquisition and downstream analysis of MR imaging modalities including but not limited to 2/3D MRE and contrast enhanced MRI, including the use of their own proprietary techniques, to assess liver structure and function and support clinical research.",
                "hasOptions": true,
                "options": {
                    "description": "Future option to develop proprietary PET-tracers targeting Collagen-1 and PDGFRbeta that may be relevant in a future extension of the scope of this project."
                }
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "73111000",
                        "description": "Research laboratory services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKC22"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "coveredBy": [
            "GPA"
        ],
        "reviewDetails": "Newcastle University will incorporate a minimum 10 calendar day standstill period at the point information on the award of the contract is communicated to tenderers. This period allows unsuccessful tenderers to seek further debriefing before the contract is entered into. Applicants have 2 working days from notification of the award decision to request additional debriefing and 4 / 4 that information has to be provided a minimum of 3 working days before expiry of the standstill period. Such additional information should be requested from the address referred to in part 1.1 above. If an appeal regarding the award of a contract has not been successfully resolved, the Public Contracts Regulations 2015 provide for aggrieved parties who have been harmed or are at risk of harm by a breach of the rules to take action in the High Court (England, Wales and Northern Ireland). Any such action must be brought promptly. Where a contract has not been entered into the Court may order the setting aside of the award decision or order the authority to amend any document and may award damages. If the contract has been entered into the Court may only award damages.",
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_OUTSIDE_SCOPE",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "procurementMethodRationale": "The intention is to award a research contract under UK Statutory Instrument 2015 No. 102 Part 2 Chapter 2 Section 3 Regulation 32(1)(b)(ii) and (iii). Where (ii) is the justification for technical reasons and (iii) is the protection of exclusive rights, including intellectual property rights. Antaros Medical have established expertise and experience of deploying advanced MR methodologies in studies that seek to investigate not only liver morphology but also downstream consequences of liver fibrosis such as liver function, portal pressure (including pressure effects on the spleen and portal resistive index) and blood flow to the spleen and kidneys. A range of imaging modalities will be employed in this project including but not limited to liver and spleen stiffness using 2/3D MRE and liver function using uptake of MRI contrast agents, where Antaros Medical have developed quantitative modelling of uptake kinetics to assess liver transporter function. Antaros Medical are also developing proprietary PET-tracers targeting Collagen-1 and PDGFRbeta that may be relevant in a future extension of the scope of this project. These tracers are Antaros Medical proprietary investigational products. Antaros medical will support deployment, acquisition and downstream analysis of MR imaging modalities including but not limited to 2/3D MRE and contrast enhanced MRI to assess liver structure and function and support the research project. In addition, Antaros Medical will collaborate as required with the academic investigators to support the downstream analysis of data, sharing know-how of advanced imaging."
    },
    "awards": [
        {
            "id": "023436-2022-NU/1804-1",
            "relatedLots": [
                "1"
            ],
            "title": "(NU/1804) Research Agreement between Newcastle University and Antaros Medical AB",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-62082",
                    "name": "Antaros Medical AB"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-168",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "streetAddress": "Newcastle University, Procurement Services, Kingsgate",
                "locality": "Newcastle",
                "region": "UKC22",
                "postalCode": "NE1 7RU",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Dr Emma Barksby",
                "telephone": "+44 1912086298",
                "email": "emma.barksby@ncl.ac.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.ncl.ac.uk",
                "buyerProfile": "https://www.ncl.ac.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "09",
                        "description": "Education"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-62082",
            "name": "Antaros Medical AB",
            "identifier": {
                "legalName": "Antaros Medical AB"
            },
            "address": {
                "streetAddress": "Bio Venture Hub, Pepparedsleden 1",
                "locality": "431 83 Molndal",
                "region": "SE",
                "countryName": "Sweden"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme"
            }
        },
        {
            "id": "GB-FTS-7395",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "locality": "Newcastle upon Tyne",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://www.ncl.ac.uk"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-168",
        "name": "Newcastle University"
    },
    "contracts": [
        {
            "id": "023436-2022-NU/1804-1",
            "awardID": "023436-2022-NU/1804-1",
            "title": "(NU/1804) Research Agreement between Newcastle University and Antaros Medical AB",
            "status": "active",
            "dateSigned": "2022-08-18T00:00:00+01:00"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "3",
                "measure": "lowestValidBidValue",
                "relatedLot": "1",
                "value": 3000000,
                "currency": "GBP"
            },
            {
                "id": "4",
                "measure": "highestValidBidValue",
                "relatedLot": "1",
                "value": 6000000,
                "currency": "GBP"
            },
            {
                "id": "1",
                "measure": "lowestValidBidValue",
                "value": 3000000,
                "currency": "GBP"
            },
            {
                "id": "2",
                "measure": "highestValidBidValue",
                "value": 6000000,
                "currency": "GBP"
            }
        ]
    },
    "language": "en"
}